Key Takeaways. LGM Pharma’s Texas expansion targets commercial suppository manufacturing and broader semi-solid/liquid ...

The attention economy’s most effective voices have mastered techniques that are compatible with pharma’s central mission: To communicate something that’s complex and high-stakes, and often alien to ...

The rise of AI has powered a wave of interest in digital innovation within pharma. But to have a lasting impact, AI — like any innovation in digital health — must be able to deliver value by being ...

As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...

A Junto Health working group meets at the last team summit. There are a lot of digital health accelerators designed to help startups catch the eye of big pilot partners, but what about the other way ...

Suzhou Zion Pharma Technology Co Ltd. has identified KRAS inhibitors, in particular GTPase KRAS G12D mutant and/or G13D mutant, reported to be useful for the treatment of cancer. Suzhou Zion Pharma ...

Suzhou Zion Pharma Technology Co Ltd. has identified KRAS inhibitors, in particular GTPase KRAS G12D mutant and/or G13D mutant, reported to be useful for the treatment of cancer.

Mitsubishi Tanabe Pharma filed a patent infringement lawsuit against Shanghai Auzone Biological Technology and its subsidiaries on Oct. 15 in New Jersey District Court. The action, which pertains to ...